Literature DB >> 8069294

Characterization and tissue-specific expression of the human 'very low density lipoprotein (VLDL) receptor' mRNA.

J C Webb1, D D Patel, M D Jones, B L Knight, A K Soutar.   

Abstract

A cDNA has been isolated from human heart that is homologous to a member of the low density lipoprotein (LDL) receptor gene family recently identified in rabbit. It was named the very low density lipoprotein (VLDL) receptor, although its physiological function is not yet known. The predicted human protein shows 97.4% sequence homology to the rabbit protein, much more than the approximately 75% observed between their LDL receptor proteins. The sequence is also highly conserved in the hamster and the African green monkey. The mRNA was identified as a 3.9 kb transcript by Northern blotting in Hep G2 cells, cultured arterial smooth muscle cells and human skin fibroblasts, where its level was unaffected by sterols. The mRNA was not detected in EBV-lymphoblasts or in monocyte-macrophages by Northern blotting or by RT-PCR. In human tissues in vivo, the mRNA was expressed predominantly in heart and skeletal muscle, and also in ovary and kidney, but not in the liver. Although the 3.9 kb mRNA was the major transcript, a larger variant of 5.2 kb was also detectable and was predominant in skeletal muscle. Amplification of the mRNA from cultured human cells also revealed a potential splice variant that lacked 84 bp coding for a region equivalent to the O-linked sugars domain of the LDL receptor. It was a minor component in most cell types, but was predominant in Hep G2 cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8069294     DOI: 10.1093/hmg/3.4.531

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  25 in total

1.  Effective generation of very low density lipoprotein receptor transgenic mice by overlapping genomic DNA fragments: high testis expression and disturbed spermatogenesis.

Authors:  P J Tacken; A van der Zee; T L Beumer; R J Florijn; M J Gijpels; L M Havekes; R R Frants; K W van Dijk; M H Hofker
Journal:  Transgenic Res       Date:  2001-06       Impact factor: 2.788

2.  Nuclear factor (erythroid-derived 2)-like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice.

Authors:  Zhigang Wang; Xiaobing Dou; Songtao Li; Ximei Zhang; Xinguo Sun; Zhanxiang Zhou; Zhenyuan Song
Journal:  Hepatology       Date:  2014-02-25       Impact factor: 17.425

Review 3.  Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.

Authors:  Nosratola D Vaziri
Journal:  Kidney Int       Date:  2016-04-26       Impact factor: 10.612

4.  Function and significance of very low density lipoprotein receptor subtype II.

Authors:  Jun Tian; Hao Bi; Yinghong Li; Pu Yang; Yiqiang Zong; Yu Wang; Shen Qu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

5.  Transcriptome Analysis of K-877 (a Novel Selective PPARα Modulator (SPPARMα))-Regulated Genes in Primary Human Hepatocytes and the Mouse Liver.

Authors:  Sana Raza-Iqbal; Toshiya Tanaka; Motonobu Anai; Takeshi Inagaki; Yoshihiro Matsumura; Kaori Ikeda; Akashi Taguchi; Frank J Gonzalez; Juro Sakai; Tatsuhiko Kodama
Journal:  J Atheroscler Thromb       Date:  2015-06-04       Impact factor: 4.928

6.  mTOR Inhibition Subdues Milk Disorder Caused by Maternal VLDLR Loss.

Authors:  HoangDinh Huynh; Wei Wei; Yihong Wan
Journal:  Cell Rep       Date:  2017-06-06       Impact factor: 9.423

7.  Synthesis and properties of the very-low-density-lipoprotein receptor and a comparison with the low-density-lipoprotein receptor.

Authors:  D D Patel; R A Forder; A K Soutar; B L Knight
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

8.  Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein.

Authors:  O M Andersen; H H Petersen; C Jacobsen; S K Moestrup; M Etzerodt; P A Andreasen; H C Thøgersen
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

9.  Investigation of the distribution and changes of VLDLR subtype in fibrotic cardiac muscles.

Authors:  G Yang; L Bao; J Zhao; S Qu
Journal:  J Tongji Med Univ       Date:  2000

Review 10.  Dynamics of hepatic and intestinal cholesterol and bile acid pathways: The impact of the animal model of estrogen deficiency and exercise training.

Authors:  Jean-Marc Lavoie
Journal:  World J Hepatol       Date:  2016-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.